Published in Nat Med on July 01, 2000
Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep (2003) 3.29
Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol (2008) 1.65
Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol (2004) 1.65
Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells. PLoS One (2011) 1.52
Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 1.40
Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol (2001) 1.31
Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol (2003) 1.18
Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells. PLoS Pathog (2014) 1.07
Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. J Virol (2007) 1.05
The importance of hematopoietic progenitor cells in dengue. Ther Adv Hematol (2012) 0.83
Modulation of cellular tropism and innate antiviral response by viral glycans. J Innate Immun (2009) 0.83
CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis. J Mol Med (Berl) (2016) 0.75
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science (2001) 8.14
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol (2000) 3.39
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res (2001) 3.01
Dendritic cells as vectors for therapy. Cell (2001) 2.18
Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med (2001) 1.85
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med (2000) 1.62
Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol (2001) 1.49
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ (2007) 1.35
Dendritic cells as melanoma vaccines. Dev Biol (Basel) (2004) 0.77
Kinetic analysis of cytotoxic lymphocyte-target cell interaction as quantified by dual parameter flow cytometry. Cytometry (1993) 0.75